vs

Side-by-side financial comparison of FIRST US BANCSHARES, INC. (FUSB) and Lakeside Holding Ltd (LSH). Click either name above to swap in a different company.

FIRST US BANCSHARES, INC. is the larger business by last-quarter revenue ($10.4M vs $7.0M, roughly 1.5× Lakeside Holding Ltd). FIRST US BANCSHARES, INC. runs the higher net margin — 20.4% vs -22.6%, a 43.0% gap on every dollar of revenue. On growth, Lakeside Holding Ltd posted the faster year-over-year revenue change (95.0% vs 7.1%).

First Citizens Bancshares, Inc. is a bank holding company based in Raleigh, North Carolina and one of the largest banks in the United States. Its primary subsidiary is First Citizens Bank, which operates over 500 branches in 23 states. A second subsidiary is Silicon Valley Bank, which operates 39 offices in 15 states.

Lakeside Press was a Chicago publishing imprint under which the RR Donnelley Company produced fine books as well as mail order catalogs, telephone directories, encyclopedias, and advertising. The Press was best known for its high quality editions for the Chicago Caxton Club as well as the Lakeside Classics, a series of fine reprints.

FUSB vs LSH — Head-to-Head

Bigger by revenue
FUSB
FUSB
1.5× larger
FUSB
$10.4M
$7.0M
LSH
Growing faster (revenue YoY)
LSH
LSH
+88.0% gap
LSH
95.0%
7.1%
FUSB
Higher net margin
FUSB
FUSB
43.0% more per $
FUSB
20.4%
-22.6%
LSH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FUSB
FUSB
LSH
LSH
Revenue
$10.4M
$7.0M
Net Profit
$2.1M
$-1.6M
Gross Margin
27.2%
Operating Margin
28.1%
-21.3%
Net Margin
20.4%
-22.6%
Revenue YoY
7.1%
95.0%
Net Profit YoY
24.2%
18.7%
EPS (diluted)
$0.36
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FUSB
FUSB
LSH
LSH
Q4 25
$10.4M
$7.0M
Q3 25
$10.5M
$6.1M
Q2 25
$10.3M
$6.3M
Q1 25
$9.8M
$3.8M
Q4 24
$9.7M
$3.6M
Q3 24
$10.1M
$4.1M
Q2 24
$10.0M
Q1 24
$9.9M
Net Profit
FUSB
FUSB
LSH
LSH
Q4 25
$2.1M
$-1.6M
Q3 25
$1.9M
$-1.4M
Q2 25
$155.0K
$-893.1K
Q1 25
$1.8M
$-1.1M
Q4 24
$1.7M
$-1.9M
Q3 24
$2.2M
$-1.3M
Q2 24
$2.1M
Q1 24
$2.1M
Gross Margin
FUSB
FUSB
LSH
LSH
Q4 25
27.2%
Q3 25
18.2%
Q2 25
26.7%
Q1 25
18.8%
Q4 24
-1.2%
Q3 24
12.8%
Q2 24
Q1 24
Operating Margin
FUSB
FUSB
LSH
LSH
Q4 25
28.1%
-21.3%
Q3 25
23.9%
-20.8%
Q2 25
1.6%
-8.9%
Q1 25
23.8%
-28.2%
Q4 24
23.8%
-55.6%
Q3 24
29.2%
-32.5%
Q2 24
27.4%
Q1 24
27.8%
Net Margin
FUSB
FUSB
LSH
LSH
Q4 25
20.4%
-22.6%
Q3 25
18.4%
-22.2%
Q2 25
1.5%
-14.2%
Q1 25
18.1%
-28.2%
Q4 24
17.6%
-54.1%
Q3 24
22.0%
-32.7%
Q2 24
21.2%
Q1 24
21.3%
EPS (diluted)
FUSB
FUSB
LSH
LSH
Q4 25
$0.36
$-0.08
Q3 25
$0.32
$-0.09
Q2 25
$0.03
$-0.11
Q1 25
$0.29
$-0.14
Q4 24
$0.29
$-0.26
Q3 24
$0.36
$-0.18
Q2 24
$0.34
Q1 24
$0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FUSB
FUSB
LSH
LSH
Cash + ST InvestmentsLiquidity on hand
$73.5M
$1.6M
Total DebtLower is stronger
$10.9M
$2.4M
Stockholders' EquityBook value
$105.6M
$12.2M
Total Assets
$1.2B
$24.3M
Debt / EquityLower = less leverage
0.10×
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FUSB
FUSB
LSH
LSH
Q4 25
$73.5M
$1.6M
Q3 25
$54.7M
$4.5M
Q2 25
$54.0M
$5.0M
Q1 25
$56.0M
$1.5M
Q4 24
$47.2M
$1.1M
Q3 24
$82.3M
$2.7M
Q2 24
$58.2M
Q1 24
$60.2M
Total Debt
FUSB
FUSB
LSH
LSH
Q4 25
$10.9M
$2.4M
Q3 25
$10.9M
$2.4M
Q2 25
$10.9M
$1.4M
Q1 25
$10.9M
$774.2K
Q4 24
$10.9M
$784.8K
Q3 24
$10.9M
$589.9K
Q2 24
$10.8M
Q1 24
$10.8M
Stockholders' Equity
FUSB
FUSB
LSH
LSH
Q4 25
$105.6M
$12.2M
Q3 25
$104.2M
$7.0M
Q2 25
$101.9M
$2.8M
Q1 25
$101.2M
$749.8K
Q4 24
$98.6M
$1.6M
Q3 24
$98.5M
$3.6M
Q2 24
$93.8M
Q1 24
$92.3M
Total Assets
FUSB
FUSB
LSH
LSH
Q4 25
$1.2B
$24.3M
Q3 25
$1.1B
$18.6M
Q2 25
$1.1B
$14.4M
Q1 25
$1.1B
$9.9M
Q4 24
$1.1B
$9.8M
Q3 24
$1.1B
$10.8M
Q2 24
$1.1B
Q1 24
$1.1B
Debt / Equity
FUSB
FUSB
LSH
LSH
Q4 25
0.10×
0.20×
Q3 25
0.10×
0.35×
Q2 25
0.11×
0.48×
Q1 25
0.11×
1.03×
Q4 24
0.11×
0.48×
Q3 24
0.11×
0.16×
Q2 24
0.12×
Q1 24
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FUSB
FUSB
LSH
LSH
Operating Cash FlowLast quarter
$12.3M
$-453.5K
Free Cash FlowOCF − Capex
$9.1M
FCF MarginFCF / Revenue
87.2%
Capex IntensityCapex / Revenue
31.1%
Cash ConversionOCF / Net Profit
5.79×
TTM Free Cash FlowTrailing 4 quarters
$16.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FUSB
FUSB
LSH
LSH
Q4 25
$12.3M
$-453.5K
Q3 25
$4.2M
$-4.0M
Q2 25
$3.9M
$-483.7K
Q1 25
$1.8M
$-238.3K
Q4 24
$7.8M
$-530.2K
Q3 24
$1.9M
$-1.4M
Q2 24
$2.5M
Q1 24
$825.0K
Free Cash Flow
FUSB
FUSB
LSH
LSH
Q4 25
$9.1M
Q3 25
$3.6M
Q2 25
$1.6M
$-497.4K
Q1 25
$1.7M
Q4 24
$5.7M
$-560.5K
Q3 24
$1.3M
$-1.4M
Q2 24
$2.3M
Q1 24
$-142.0K
FCF Margin
FUSB
FUSB
LSH
LSH
Q4 25
87.2%
Q3 25
34.2%
Q2 25
16.0%
-7.9%
Q1 25
17.2%
Q4 24
58.2%
-15.6%
Q3 24
12.7%
-34.5%
Q2 24
23.5%
Q1 24
-1.4%
Capex Intensity
FUSB
FUSB
LSH
LSH
Q4 25
31.1%
Q3 25
5.9%
Q2 25
21.8%
0.2%
Q1 25
0.7%
0.0%
Q4 24
21.6%
0.8%
Q3 24
6.6%
0.1%
Q2 24
2.0%
Q1 24
9.8%
Cash Conversion
FUSB
FUSB
LSH
LSH
Q4 25
5.79×
Q3 25
2.18×
Q2 25
25.16×
Q1 25
0.99×
Q4 24
4.53×
Q3 24
0.87×
Q2 24
1.20×
Q1 24
0.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FUSB
FUSB

Segment breakdown not available.

LSH
LSH

Transferred Over Time$4.6M65%
Distribution Of Pharmaceutical Products$2.4M35%

Related Comparisons